Navigation Links
The Mental Health Gender Gap: Women Far Exceed Men in their Use of Psychotropic Medications as Utilization Increases Among Both Sexes
Date:3/19/2012

WASHINGTON, March 19, 2012 /PRNewswire/ -- Women far outpace their male counterparts when it comes to the consumption of mental health medications, with 25 percent using at least one psychotropic drug as compared to 15 percent of men.  These are findings from research by Medco Health Solutions, Inc. (NYSE: MHS) that were presented Saturday at the 2012 Women's Health Congress.

(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO )

The study reviewed the pharmacy claims of more than two million insured Americans and assessed the use of antidepressants, antipsychotics, anti-anxiety medications and drugs to treat attention deficit hyperactivity disorder (ADHD) between 2001 and 2010. 

"Some mental health medications such as antidepressants have historically been more widely used by women than men," said lead researcher, Dr. David Muzina, a psychiatrist and national practice leader of the Medco Neuroscience Therapeutic Resource Center®.   "However, what is surprising is how many women are taking these medications and the substantial increase in the number of women on treatments that have traditionally not been heavily used by females, like ADHD drugs." 

The research shows that antidepressants are by far the most commonly utilized psychotropic medication, with 21 percent of women on one of these drugs in 2010.  Both men and women's use increased about 29 percent from the start of the decade, but the number of men taking antidepressants remained about half that of women at 11 percent.

Women also trump men in utilization of anti-anxiety medications. Eleven percent of women ages 45-64 were on an anti-anxiety medication – nearly twice the rate (5.7 percent) of their male counterparts.

While far more boys than girls take ADHD medications, a higher number of women than men are utilizing them as adults.  Females aged 20-44 had the highest use among adults as their utilization rose a staggering 264 percent over the decade, as compared to a 188 percent increase for males the same age.   

A similar pattern was seen for those using atypical antipsychotics; while males had the highest use in childhood, females were more likely to be prescribed these drugs in adulthood.  However, the rate of growth increased more rapidly for men than women over the decade.

"These findings confirm that mental illness is a growing problem in the United States and that more patients are seeking needed therapy," said Muzina. "However, adequate monitoring by pharmacists and physicians and an open patient dialogue is imperative due to the complexities of mental illness and the risk of taking these medications inappropriately."

Patients suffering from behavioral health disorders along with other related conditions benefit from the expertise of Medco's specialist pharmacists who have advanced training and expertise in these and other health conditions including diabetes, cardiovascular disease, pulmonary conditions and cancer.  Specialist pharmacist are also better equipped to identify and address medication adherence problems which is especially important for those with mental health conditions since research shows these patients are more prone to poor adherence with medications used to treat comorbidities such as diabetes, asthma and heart disease and, in general, have poorer health outcomes.          

For more information on mental health medication use, visit America's State of Mind Report at www.medco.com/media

About Medco
Medco Health Solutions, Inc. (NYSE: MHS) is pioneering The world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for millions of Americans.

With more than 20,000 employees worldwide dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2011 revenues of $70 billion, Medco ranks 34th on the 2011 Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies. 

For more information, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kevin McHale Instrumental in Forming the Help Me Hear Foundation
2. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
3. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
4. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
5. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
6. Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study
7. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
8. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
9. Testosterone May Improve Mental Function, From the Harvard Mens Health Watch
10. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
11. Childrens Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016 Exactus ... company providing high-quality specialty pharmacy care for those ... today it has achieved full Specialty Pharmacy Accreditation ... organization dedicated to promoting health care quality through ... --> The URAC accreditation process ...
(Date:2/11/2016)... , Feb. 11, 2016 Scientists from ... method that opens the door to genetic analysis ... have been impossible to isolate with 100 percent ... specific tumor types in various stages of development, ... of these cells that are clinically relevant, and ...
(Date:2/11/2016)... , Feb. 11, 2016  AcelRx Pharmaceuticals, Inc. (NASDAQ: ... will be made at the 38th annual John ... Care Symposium, which is being held February 14-18, 2016 ... covers the latest advancements in wound healing, burn care, ... Burn Association, Australian-New Zealand Burns Association, Academy of Physicians ...
Breaking Medicine Technology:
(Date:2/11/2016)... , ... February 11, 2016 , ... ... with their ongoing community involvement program, introduces a new charity campaign to raise ... donations are now being accepted at https://donate.rmhc.org/ . , Ronald McDonald House ...
(Date:2/11/2016)... ... 2016 , ... Be Well Medical Group (Be Well) is pleased ... at 108 South Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group is ... the convenience of their homes, offices or at the practices’ local office. It is ...
(Date:2/11/2016)... ... February 11, 2016 , ... Food Labeling ... in health and wellness best practices in the past couple of decades, and ... is American Heart Month, which acts as an exceptional opportunity to revise food ...
(Date:2/10/2016)... ... February 10, 2016 , ... President ... Medicare Advantage organizations to deliver medical services via telehealth, estimated to generate more ... advocating for such language for many years. Although there is more to ...
(Date:2/10/2016)... ... ... LaserShip, a regional parcel carrier that services the eastern U.S., donated and delivered ... order to aid in the Flint water crisis. In 2014, LaserShip acquired Prestige Delivery ... only 15 miles away from Flint. , “We have deep roots in the local ...
Breaking Medicine News(10 mins):